Amplify Weight Loss Drug & Treatment ETF (THNR) ETF Holdings & Portfolio Analysis - Complete Fund Breakdown - Stocknear

Amplify Weight Loss Drug ...

AMEX: THNR · Real-Time Price · USD
22.86
0.02 (0.07%)
At close: Sep 29, 2025, 3:49 PM
22.92
0.28%
After-hours: Sep 29, 2025, 04:04 PM EDT

THNR Holdings List

As of Sep 29, 2025
The Amplify Weight Loss Drug & Treatment ETF is an equity ETF with a total of 11 individual holdings. The top holdings are Novo Nordisk A/S at 12.88%, Eli Lilly and Company at 12.06%, Regeneron Pharmaceuticals at 6.65%, Amgen at 6.48%, and Hims & Hers Health at 5.68%.
11
64.81%
Equity
2.97M
21.01
0.5900%

Sector Allocation

Rank Symbol Name Price % Change Shares % Weight
1 NVO Novo Nordisk A/...
55.52
-0.17% 6.89K 12.88%
2 LLY Eli Lilly and C...
726.48
+0.27% 495 12.06%
3 REGN Regeneron Pharm...
560.75
-0.56% 351 6.65%
4 AMGN Amgen Inc.
273.97
+0.36% 706 6.48%
5 HIMS Hims & Hers Hea...
59.12
+1.23% 2.89K 5.68%
6 ABBV AbbVie Inc.
223.19
+1.17% 680 5.04%
7 PFE Pfizer Inc.
23.84
+0.32% 6.02K 4.81%
8 MRK Merck & Co., In...
78.58
+0.02% 1.76K 4.64%
9 AZN AstraZeneca PLC
74.13
+0.50% 1.85K 4.58%
10 SRRK Scholar Rock Ho...
38.36
-1.01% 1.53K 1.99%
11 MTSR Metsera, Inc.
52.10
-0.29% 959 1.68%